Excelsior Medical Co Ltd - Asset Resilience Ratio
Excelsior Medical Co Ltd (4104) has an Asset Resilience Ratio of 3.70% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Excelsior Medical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2024)
This chart shows how Excelsior Medical Co Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Excelsior Medical Co Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Excelsior Medical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4104 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$695.39 Million | 3.7% |
| Total Liquid Assets | NT$695.39 Million | 3.70% |
Asset Resilience Insights
- Limited Liquidity: Excelsior Medical Co Ltd maintains only 3.70% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Excelsior Medical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Excelsior Medical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for Excelsior Medical Co Ltd (2007–2024)
The table below shows the annual Asset Resilience Ratio data for Excelsior Medical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.72% | NT$757.57 Million ≈ $23.87 Million |
NT$20.37 Billion ≈ $641.70 Million |
-0.66pp |
| 2023-12-31 | 4.38% | NT$791.28 Million ≈ $24.93 Million |
NT$18.08 Billion ≈ $569.62 Million |
0.00pp |
| 2022-12-31 | 4.38% | NT$721.62 Million ≈ $22.73 Million |
NT$16.48 Billion ≈ $519.29 Million |
-0.25pp |
| 2021-12-31 | 4.63% | NT$699.40 Million ≈ $22.03 Million |
NT$15.11 Billion ≈ $475.89 Million |
-2.06pp |
| 2020-12-31 | 6.69% | NT$936.33 Million ≈ $29.50 Million |
NT$14.00 Billion ≈ $441.22 Million |
+2.44pp |
| 2019-12-31 | 4.24% | NT$583.92 Million ≈ $18.40 Million |
NT$13.76 Billion ≈ $433.67 Million |
+1.93pp |
| 2018-12-31 | 2.32% | NT$323.69 Million ≈ $10.20 Million |
NT$13.98 Billion ≈ $440.47 Million |
-4.72pp |
| 2017-12-31 | 7.03% | NT$1.05 Billion ≈ $33.13 Million |
NT$14.95 Billion ≈ $471.05 Million |
-1.64pp |
| 2016-12-31 | 8.67% | NT$1.46 Billion ≈ $45.96 Million |
NT$16.83 Billion ≈ $530.11 Million |
+3.19pp |
| 2015-12-31 | 5.48% | NT$855.74 Million ≈ $26.96 Million |
NT$15.62 Billion ≈ $491.96 Million |
-1.87pp |
| 2014-12-31 | 7.35% | NT$1.09 Billion ≈ $34.47 Million |
NT$14.88 Billion ≈ $468.89 Million |
+4.84pp |
| 2013-12-31 | 2.52% | NT$357.09 Million ≈ $11.25 Million |
NT$14.19 Billion ≈ $447.12 Million |
+1.06pp |
| 2012-12-31 | 1.45% | NT$190.00 Million ≈ $5.99 Million |
NT$13.09 Billion ≈ $412.38 Million |
+1.44pp |
| 2011-12-31 | 0.01% | NT$1.72 Million ≈ $54.09K |
NT$12.51 Billion ≈ $394.16 Million |
-0.20pp |
| 2010-12-31 | 0.22% | NT$25.47 Million ≈ $802.54K |
NT$11.69 Billion ≈ $368.27 Million |
-0.12pp |
| 2009-12-31 | 0.34% | NT$30.80 Million ≈ $970.31K |
NT$9.14 Billion ≈ $287.81 Million |
-0.12pp |
| 2008-12-31 | 0.45% | NT$21.70 Million ≈ $683.76K |
NT$4.77 Billion ≈ $150.37 Million |
-3.71pp |
| 2007-12-31 | 4.16% | NT$195.54 Million ≈ $6.16 Million |
NT$4.70 Billion ≈ $148.07 Million |
-- |
About Excelsior Medical Co Ltd
Excelsior Medical Co., Ltd., together with its subsidiaries, sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates in four segments: Excelsior, Dynamic, Arich, and Other. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in… Read more